Pemirolast ophthalmic Pregnancy and Breastfeeding Warnings
Pemirolast ophthalmic is also known as: Alamast
Pemirolast ophthalmic Pregnancy Warnings
Pemirolast ophthalmic has been assigned to pregnancy category C by the FDA. Animal studies have revealed evidence of skeletal abnormalities and dilation of the renal pelvis and ureters in rats given pemirolast at 20,000 times the usual human dose. There are no controlled data in human pregnancy. Pemirolast undergoes low systemic absorption after ocular administration (average plasma concentration: 0.8 ng/mL). Pemirolast ophthalmic is only recommended for use during pregnancy when benefit outweighs risk.
Pemirolast ophthalmic Breastfeeding Warnings
There are no data on the excretion of pemirolast ophthalmic into human milk. It is excreted into rat milk at concentrations higher than in plasma. Pemirolast undergoes low systemic absorption after ocular administration (0.8 ng/mL). The manufacturer recommends caution when administering pemirolast ophthalmic to nursing women.
See Also...
- Pemirolast use while Breastfeeding (in more detail)
- pemirolast Consumer Information
- Pregnancy Support Group
- FDA Pregnancy Categories
- Medicine use during Pregnancy
- Medicine use while Breastfeeding
- Safe Medications during Breastfeeding
Disclaimer: Every effort has been made to ensure that the information provided by Cerner Multum, Wolters Kluwer Health and Drugs.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. In addition, the drug information contained herein may be time sensitive and should not be utilized as a reference resource beyond the date hereof. This drug information does not endorse drugs, diagnose patients, or recommend therapy. This drug information is a reference resource designed as supplement to, and not a substitute for, the expertise, skill , knowledge, and judgement of healthcare practitioners in patient care. The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug of drug combination is safe, effective, or appropriate for any given patient. Multum Information Services, Inc. does not assume any responsibility for any aspect of healthcare administered with the aid of information Multum provides. Copyright 2000-2008 Multum Information Services, Inc. The information in contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse, or pharmacist.
